WELL Health Technologies (TSE:WELL) Price Target Raised to C$7.00

WELL Health Technologies (TSE:WELL) had its price objective raised by Scotiabank from C$6.00 to C$7.00 in a report released on Monday morning,BayStreet.CA reports.

A number of other research analysts also recently commented on WELL. CIBC increased their target price on shares of WELL Health Technologies from C$5.25 to C$7.00 in a research report on Friday, December 13th. Haywood Securities boosted their target price on WELL Health Technologies from C$8.00 to C$10.00 in a report on Friday, December 13th. Finally, Ventum Financial dropped their price target on WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating on the stock in a research note on Tuesday, October 29th.

WELL Health Technologies Price Performance

WELL stock opened at C$7.00 on Monday. The company has a quick ratio of 1.02, a current ratio of 1.25 and a debt-to-equity ratio of 41.57. WELL Health Technologies has a fifty-two week low of C$3.41 and a fifty-two week high of C$7.19. The business has a 50 day moving average price of C$5.29 and a 200 day moving average price of C$4.75. The stock has a market cap of C$1.74 billion, a price-to-earnings ratio of 12.28, a PEG ratio of -1.93 and a beta of 1.20.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.